• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿路感染患者中产超广谱β-内酰胺酶肺炎克雷伯菌的发生率。

Incidence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in patients with urinary tract infection.

作者信息

Ghafourian Sobhan, Sekawi Zamberi, Neela Vasanthakumari, Khosravi Afra, Rahbar Mohammad, Sadeghifard Nourkhoda

机构信息

Ilam University of Medical Sciences, Ilam, Iran.

出版信息

Sao Paulo Med J. 2012;130(1):37-43. doi: 10.1590/s1516-31802012000100007.

DOI:10.1590/s1516-31802012000100007
PMID:22344358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10906682/
Abstract

CONTEXT AND OBJECTIVES

Resistant bacteria are emerging worldwide as a threat to favorable outcomes from treating common infections in community and hospital settings. The present investigation was carried out to study the incidence of extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae in patients with urinary tract infection in different seasons of the year, in order to determine the prevalence of the genes blaTEM, blaSHV and blaCTX-M, which are responsible for ESBL production among ESBL-producing K. pneumoniae, in three cities in Iran, and to investigate the antimicrobial susceptibility pattern of K. pneumoniae in different seasons.

DESIGN AND SETTING

Retrospective study carried out among patients with urinary tract infections in five hospitals in Iran.

METHOD

Two hundred and eighty-eight clinical isolates of K. pneumoniae were collected between March 2007 and April 2008 from five hospitals in three cities in Iran. ESBLs were identified by phenotypic and genotypic methods. ESBL-producing Klebsiella pneumoniae were evaluated against non-beta-lactam antibiotics. Genes coding for ESBLs (blaSHV, TEM and CTX-M) were screened.

RESULTS

Among the 288 clinical isolates of K. pneumoniae, 37.7%, 46.7% and 15.6% were obtained from hospitals in Ilam, Tehran and Tabriz, respectively, of which 39.4%, 50.7% and 45.8% were ESBL-producing K. pneumoniae in Ilam, Milad and Emam Reza hospitals, respectively.

CONCLUSION

According to the results from this study, resistance to third-generation cephalosporins is higher during the cold months than during the warm months.

摘要

背景与目的

耐药菌在全球范围内不断出现,对社区和医院环境中常见感染的治疗效果构成威胁。本研究旨在调查一年中不同季节尿路感染患者中产超广谱β-内酰胺酶(ESBL)的肺炎克雷伯菌的发生率,以确定负责产ESBL的肺炎克雷伯菌中ESBL产生的blaTEM、blaSHV和blaCTX-M基因在伊朗三个城市的流行情况,并调查不同季节肺炎克雷伯菌的抗菌药敏模式。

设计与背景

对伊朗五家医院的尿路感染患者进行回顾性研究。

方法

2007年3月至2008年4月期间,从伊朗三个城市的五家医院收集了288株肺炎克雷伯菌临床分离株。通过表型和基因型方法鉴定ESBL。对产ESBL的肺炎克雷伯菌进行非β-内酰胺类抗生素评估。筛选编码ESBL的基因(blaSHV、TEM和CTX-M)。

结果

在288株肺炎克雷伯菌临床分离株中,分别有37.7%、46.7%和15.6%来自伊拉姆、德黑兰和大不里士的医院,其中在伊拉姆医院、米拉德医院和伊玛目礼萨医院产ESBL的肺炎克雷伯菌分别占39.4%、50.7%和45.8%。

结论

根据本研究结果,寒冷月份对第三代头孢菌素的耐药性高于温暖月份。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b188/10906682/5ca3b4991a45/1806-9460-spmj-130-01-37-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b188/10906682/5ca3b4991a45/1806-9460-spmj-130-01-37-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b188/10906682/5ca3b4991a45/1806-9460-spmj-130-01-37-gf1.jpg

相似文献

1
Incidence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in patients with urinary tract infection.尿路感染患者中产超广谱β-内酰胺酶肺炎克雷伯菌的发生率。
Sao Paulo Med J. 2012;130(1):37-43. doi: 10.1590/s1516-31802012000100007.
2
An Outbreak of ESBL-producing Klebsiella pneumoniae in an Iranian Referral Hospital: Epidemiology and Molecular Typing.伊朗一家转诊医院产超广谱β-内酰胺酶肺炎克雷伯菌的暴发:流行病学与分子分型
Infect Disord Drug Targets. 2019;19(1):46-54. doi: 10.2174/1871526518666180507121831.
3
Detection of Extended-Spectrum Beta-Lactamases (ESBLs) and Antibiotic Susceptibility Patterns in Klebsiella pneumoniae in Western, Iran.伊朗西部肺炎克雷伯菌中广谱β-内酰胺酶(ESBLs)的检测及抗生素敏感性模式
Infect Disord Drug Targets. 2018;18(2):156-163. doi: 10.2174/1871526517666170713101734.
4
Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.产超广谱β-内酰胺酶肺炎克雷伯菌引起的社区获得性尿路感染:病例对照对照研究。
Int J Antimicrob Agents. 2017 Aug;50(2):197-202. doi: 10.1016/j.ijantimicag.2017.03.009. Epub 2017 May 24.
5
Multidrug-resistant Klebsiella pneumoniae harboring extended spectrum β-lactamase encoding genes isolated from human septicemias.从脓毒症患者中分离到携带产超广谱β-内酰胺酶基因的多重耐药肺炎克雷伯菌。
PLoS One. 2021 May 4;16(5):e0250525. doi: 10.1371/journal.pone.0250525. eCollection 2021.
6
The Occurrence of bla extended-spectrum β-lactamase Among Clinical Isolates of Klebsiella pneumoniae in Khorramabad, Iran.伊朗霍拉马巴德地区肺炎克雷伯菌中产 bla 类扩展型β-内酰胺酶的出现。
Infect Disord Drug Targets. 2020;20(4):506-510. doi: 10.2174/1871526519666191119122059.
7
Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China.中国9家三级医院产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌引起腹腔感染的分子特征
Diagn Microbiol Infect Dis. 2017 Jan;87(1):45-48. doi: 10.1016/j.diagmicrobio.2016.10.007. Epub 2016 Oct 7.
8
A simple multiplex PCR for assessing prevalence of extended-spectrum β-lactamases producing Klebsiella pneumoniae in Intensive Care Units of a referral hospital in Shiraz, Iran.一种简单的多重 PCR 方法,用于评估伊朗设拉子转诊医院重症监护病房中产超广谱β-内酰胺酶的肺炎克雷伯菌的流行情况。
Asian Pac J Trop Med. 2013 Sep;6(9):703-8. doi: 10.1016/S1995-7645(13)60122-4.
9
High prevalence of ESBL-producing Klebsiella pneumoniae in clinical samples from central Côte d'Ivoire.科特迪瓦中部临床样本中产超广谱β-内酰胺酶肺炎克雷伯菌的高流行率。
Int J Infect Dis. 2020 Feb;91:207-209. doi: 10.1016/j.ijid.2019.11.024. Epub 2019 Nov 23.
10
Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran.伊朗德黑兰 Labbafinejad 医院临床分离肺炎克雷伯菌中 bla(TEM)、bla(SHV)、bla(CTX-M) 基因的分布。
Microb Drug Resist. 2010 Mar;16(1):49-53. doi: 10.1089/mdr.2009.0096.

引用本文的文献

1
Characterization and genome analysis of novel Klebsiella pneumoniae phage vbKpUKJ_2 isolated from hospital sewage water.从医院污水中分离出的新型肺炎克雷伯菌噬菌体vbKpUKJ_2的特性及基因组分析
BMC Microbiol. 2025 Feb 26;25(1):96. doi: 10.1186/s12866-025-03813-y.
2
Comparing the effect of peri-operative antibiotic prophylaxis only with continuous low-dose antibiotic treatment on the incidence of urinary tract infection and stent related-symptoms in patients undergoing Double-J (DJ) stent insertion following transurethral lithotripsy (TUL).比较围手术期仅使用抗生素预防与持续低剂量抗生素治疗对行经尿道碎石取石术(TUL)后行双 J(DJ)支架置入术患者的尿路感染和支架相关症状发生率的影响。
World J Urol. 2023 Nov;41(11):3027-3032. doi: 10.1007/s00345-023-04585-8. Epub 2023 Sep 29.
3

本文引用的文献

1
Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia.沙特阿拉伯利雅得产超广谱β-内酰胺酶肺炎克雷伯菌的患病率及分子特征
Ann Saudi Med. 2009 Jul-Aug;29(4):253-7. doi: 10.4103/0256-4947.55306.
2
Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran.从德黑兰患者中分离出的肺炎克雷伯菌菌株中 TEM 和 SHV β-内酰胺酶基因的分布情况。
Med Sci Monit. 2007 Nov;13(11):BR247-250.
3
Extended spectrum -lactamases (ESBL) - an emerging threat to clinical therapeutics.
Prevalence of multidrug-resistant and extended-spectrum β-lactamase-producing from chicken farms in Egypt.埃及养鸡场中耐多药和产超广谱β-内酰胺酶细菌的流行情况。
Vet World. 2023 May;16(5):1001-1007. doi: 10.14202/vetworld.2023.1001-1007. Epub 2023 May 13.
4
Assessment of ß-lactams and Carbapenems Antimicrobials Resistance in Isolated from Patients with Urinary Tract Infections in Najaf, Iraq.评估在伊拉克纳杰夫从尿路感染患者中分离的β-内酰胺类和碳青霉烯类抗菌药物耐药性。
Arch Razi Inst. 2022 Apr 30;77(2):669-673. doi: 10.22092/ARI.2022.356957.1947. eCollection 2022 Apr.
5
Antibiotic resistance modifying ability of phytoextracts in anthrax biological agent Bacillus anthracis and emerging superbugs: a review of synergistic mechanisms.植物提取物对炭疽生物剂炭疽芽孢杆菌和新兴超级细菌的抗生素耐药性修饰能力:协同机制综述。
Ann Clin Microbiol Antimicrob. 2021 Dec 2;20(1):79. doi: 10.1186/s12941-021-00485-0.
6
High frequency of multidrug-resistant (MDR) Klebsiella pneumoniae harboring several β-lactamase and integron genes collected from several hospitals in the north of Iran.从伊朗北部几家医院采集的产多种β-内酰胺酶和整合子基因的多重耐药(MDR)肺炎克雷伯菌高频出现。
Ann Clin Microbiol Antimicrob. 2021 Sep 28;20(1):70. doi: 10.1186/s12941-021-00476-1.
7
The Phylogenetic Relatedness of Harboring Extended-Spectrum β-Lactamase Producing Uropathogenic and in the North of Iran.伊朗北部携带产超广谱β-内酰胺酶的尿路致病性大肠杆菌的系统发育相关性
Infect Drug Resist. 2020 Feb 25;13:651-657. doi: 10.2147/IDR.S230335. eCollection 2020.
8
Prevalence of Gene among Extended-Spectrum β-Lactamases Producing Clinical Isolates in Iran: A Meta-Analysis.伊朗产超广谱β-内酰胺酶临床分离株中某基因的流行率:一项荟萃分析。
Iran J Med Sci. 2018 Jul;43(4):347-354.
9
Prevalence and antibiotic resistance pattern of bacteria isolated from urinary tract infections in Northern Iran.伊朗北部尿路感染分离出细菌的患病率及抗生素耐药模式
J Res Med Sci. 2017 Sep 26;22:108. doi: 10.4103/jrms.JRMS_889_16. eCollection 2017.
10
Determining frequency of genes of CTX-M and CTX-M-15 of producing of isolated extended-spectrum beta-lactamases from clinical samples of patients referred to training hospitals of Medical Sciences University, Khorramabad, Iran.确定从伊朗霍拉马巴德医科大学培训医院患者临床样本中分离出的产超广谱β-内酰胺酶的CTX-M和CTX-M-15基因的频率。
Int J Pharm Investig. 2017 Apr-Jun;7(2):60-69. doi: 10.4103/jphi.JPHI_4_17.
超广谱β-内酰胺酶(ESBL)——临床治疗面临的新威胁。
Indian J Med Microbiol. 2004 Apr-Jun;22(2):75-80.
4
Prevalence & antimicrobial resistance pattern of extended spectrum beta-lactamase producing Klebsiella spp isolated from cases of neonatal septicaemia.从新生儿败血症病例中分离出的产超广谱β-内酰胺酶克雷伯菌属的患病率及抗菌药物耐药模式
Indian J Med Res. 2007 Jan;125(1):89-94.
5
Extended-spectrum beta-lactamases: a clinical update.超广谱β-内酰胺酶:临床最新进展
Clin Microbiol Rev. 2005 Oct;18(4):657-86. doi: 10.1128/CMR.18.4.657-686.2005.
6
Molecular characterization of TEM- and SHV-derived extended-spectrum beta-lactamases in hospital-based Enterobacteriaceae in Turkey.土耳其医院内肠杆菌科细菌中 TEM 型和 SHV 型超广谱β-内酰胺酶的分子特征分析
Jpn J Infect Dis. 2005 Jun;58(3):162-7.
7
The impact of beta-lactamases on the development of novel antimicrobial agents.β-内酰胺酶对新型抗菌药物研发的影响。
Curr Opin Investig Drugs. 2002 Sep;3(9):1284-90.
8
Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province.浙江省产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌的流行病学及耐药性研究
Chin Med J (Engl). 2002 Oct;115(10):1479-82.
9
Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.21世纪的超广谱β-内酰胺酶:这种重要耐药威胁的特征、流行病学及检测
Clin Microbiol Rev. 2001 Oct;14(4):933-51, table of contents. doi: 10.1128/CMR.14.4.933-951.2001.
10
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.头孢菌素治疗由产生超广谱β-内酰胺酶的明显敏感菌引起的严重感染的结果:对临床微生物实验室的启示
J Clin Microbiol. 2001 Jun;39(6):2206-12. doi: 10.1128/JCM.39.6.2206-2212.2001.